Citation: I. Scharrer et Hj. Ehrlich, Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII, HAEMOPHILIA, 7(4), 2001, pp. 346-348
Authors:
Scandella, DH
Nakai, H
Felch, M
Mondorf, W
Scharrer, I
Hoyer, LW
Saenko, EL
Citation: Dh. Scandella et al., In hemophilia A and autoantibody inhibitor patients: The factor VIII A2 domain and light chain are most immunogenic, THROMB RES, 101(5), 2001, pp. 377-385
Authors:
Kacer, B
Hattenbach, LO
Horle, S
Scharrer, I
Kroll, P
Koch, F
Citation: B. Kacer et al., Central retinal vein occlusion and nonarteritic ischemic optic neuropathy in 2 patients with mild iron deficiency anemia, OPHTHALMOLA, 215(2), 2001, pp. 128-131
Authors:
Scharrer, I
Brackmann, HH
Sultan, Y
Abshire, T
Gazengel, C
Ragni, M
Gorina, E
Vosburgh, E
Kellermann, E
Citation: I. Scharrer et al., Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A, HAEMOPHILIA, 6(6), 2000, pp. 614-618
Authors:
Beeck, H
Nagel, D
Pindur, G
Scharrer, I
Preiss, A
Seiler, D
Hellstern, P
Citation: H. Beeck et al., Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays, BL COAG FIB, 11(2), 2000, pp. 127-135
Authors:
Abshire, TC
Brackmann, HH
Scharrer, I
Hoots, K
Gazengel, C
Powell, JS
Gorina, E
Kellermann, E
Vosburgh, E
Citation: Tc. Abshire et al., Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - Results of a multicenter, international, clinical investigation, THROMB HAEM, 83(6), 2000, pp. 811-816
Authors:
Hogan, KA
Lord, ST
Okumura, N
Terasawa, F
Galankis, DK
Scharrer, I
Gorkun, OV
Citation: Ka. Hogan et al., A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV, THROMB HAEM, 83(4), 2000, pp. 592-597
Authors:
von Depka, M
Nowak-Gottl, U
Eisert, R
Dieterich, C
Barthels, M
Scharrer, I
Ganser, A
Ehrenforth, S
Citation: M. Von Depka et al., Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism, BLOOD, 96(10), 2000, pp. 3364-3368
Authors:
Ehrenforth, S
Klinke, S
Prondzinski, MVD
Kreuz, W
Ganser, A
Scharrer, I
Citation: S. Ehrenforth et al., Resistance to activated protein C in patients with deep vein thrombosis and or pulmonary embolism: molecular genetic study of prevalence among patients from various regions in Germany, DEUT MED WO, 124(25-26), 1999, pp. 783-787
Citation: I. Scharrer, Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency, HAEMOPHILIA, 5(4), 1999, pp. 253-259
Citation: I. Scharrer et al., Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates, HAEMOPHILIA, 5(3), 1999, pp. 145-154
Authors:
Brackmann, HH
Lenk, H
Scharrer, I
Auerswald, G
Kreuz, W
Citation: Hh. Brackmann et al., German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies, HAEMOPHILIA, 5(3), 1999, pp. 203-206
Authors:
Ehrenforth, S
Prondsinski, MV
Aygoren-Pursun, E
Scharrer, I
Ganser, A
Citation: S. Ehrenforth et al., Study of the prothrombin gene 20201 GA variant in FV : Q(506) carriers in relationship to the presence or absence of juvenile venous thromboembolism, ART THROM V, 19(2), 1999, pp. 276-280
Authors:
Ehrenforth, S
Junker, R
Koch, HG
Kreuz, W
Munchow, N
Scharrer, I
Nowak-Gottl, U
Citation: S. Ehrenforth et al., Multicentre evaluation of combined prothrombotic: defects associated with thrombophilia in childhood, EUR J PED, 158, 1999, pp. S97-S104
Authors:
Becker, S
Schneider, W
Kreuz, W
Jacobi, G
Scharrer, I
Nowak-Gottl, U
Citation: S. Becker et al., Post-trauma coagulation and fibrinolysis in children suffering from severecerebro-cranial trauma, EUR J PED, 158, 1999, pp. S197-S202
Citation: Aa. Kurth et al., Prevalence, pathophysiology, diagnosis, and treatment of Willebrand syndrome in orthopedic-trauma patients, ORTHOPADE, 28(4), 1999, pp. 366-374
Authors:
Hattenbach, LO
Wellermann, G
Steinkamp, GWK
Scharrer, I
Koch, FHJ
Ohrloff, C
Citation: Lo. Hattenbach et al., Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion, OPHTHALMOLA, 213(6), 1999, pp. 360-366
Authors:
Schachinger, V
Britten, MB
Elsner, M
Walter, DH
Scharrer, I
Zeiher, AM
Citation: V. Schachinger et al., A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation, CIRCULATION, 100(14), 1999, pp. 1502-1508